Sapu Bioscience Expands International IP Coverage for OT-101
15 Feb 2026 //
GLOBENEWSWIRE
Oncotelic Therapeutics & Sapu Bio Expand Global IP for OT-101
12 Feb 2026 //
GLOBENEWSWIRE
Sapu Bioscience Boosts Taxane Therapies With TGFB2 Strategy
17 Dec 2025 //
GLOBENEWSWIRE
Oncotelic & Sapu Bio Publish Sub-15 Nm Nanoparticles Study
11 Nov 2025 //
GLOBENEWSWIRE
SAPU Bio`s TGFB2 Tied to Survival in Young Pancreatic Cancer
17 Jul 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support